Skip to main content
Log in

Type I β-lactamases ofEnterobacter cloacae and resistance to β-lactam antibiotics

  • Papers
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

The interaction of type-I β-lactamases fromEnterobacter cloacae with diverse β-lactam compounds was examined. The ability of penicillin and cefoxitin to induce β-lactamase production in this strain was assessed. The effect of β-lactamase inhibitors was measured on β-lactamase extracts and on intact cells.E. cloacae 78 strain is a stably derepressed mutant showing limited susceptibility to a number of antibiotics except imipenem. Imipenem would therefore be the appropiate choice for therapy of infections caused by stably derepressed mutants ofEnterobacter sp. producing type-I β-lactamases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bellido F., Pechère J.C., Hancock R.E.: Reevaluation of the factors involved in the efficacy of new β-lactams againstEnterobacter cloacae.Antimicrob. Agents Chemother. 35, 73–78 (1991).

    PubMed  CAS  Google Scholar 

  • Bush K., Sykes R.B.: Methodology for the study of β-lactamases.Antimicrob. Agents Chemother. 30, 6–10 (1986).

    PubMed  CAS  Google Scholar 

  • Li J.T., Moosdeen F., Williams J.D.: The effect of inhibitors of β-lactamases on β-lactamase extracts and on intact cells.J. Antimicrob. Chemother. 9, 287–296 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Maniatis T., Fritsh E.F., Sambrook J.:Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory Press, New York 1982.

    Google Scholar 

  • Miró E., Alonso C., Navarro F., Mirelis B., Prats G.: Resistencia al imipenem enEnterobacter aerogenes.Enferm. Infecc. Microbiol. Clin. 13, 278–282 (1995).

    PubMed  Google Scholar 

  • Navarro F., Alonso C., Ballús J., Miró E., March F., Coll P., Mirelis B.: Relevancia clínica de las bacterias gramnegativas que poseen betalactamasa cromosómica inducible en una unidad de cuidados intensivos.Enferm. Infecc. Microbiol. Clin. 14, 171–176 (1996).

    PubMed  CAS  Google Scholar 

  • Okonogi K., Sugiura M., Kuno M., Higashide E., Kondo M., Imada A.: Effect of β-lactamase induction on susceptibility to cephalosporins inEnterobacter cloacae andSerratia marcescens.J. Antimicrob. Chemother. 16, 31–42 (1985).

    Article  PubMed  CAS  Google Scholar 

  • Sanders C.C., Sanders W.E.: Type-I β-lactamases of Gram-negative bacteria: interactions with β-lactam antibiotics.J. Infect. Dis. 154, 792–800 (1986).

    PubMed  CAS  Google Scholar 

  • Shannon K., King A., Phillips I.: β-Lactamases with high activity against imipenem and Sch 34343 fromAeromonas hydrophila.J. Antimicrob. Chemother. 17, 45–50 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Suginaka H., Kotani N., Takata N., Ogawa M.: Effect of cefotaxime (HR-756) on biosynthesis of cell wall peptidoglycan inPseudomonas aeruginosa KM 338 andEscherichia coli K12.FEMS Microbiol. Lett. 8, 79–82 (1980).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tejedor-Junco, M.T., González-Martín, M., Lupiola, P. et al. Type I β-lactamases ofEnterobacter cloacae and resistance to β-lactam antibiotics. Folia Microbiol 43, 683–686 (1998). https://doi.org/10.1007/BF02816390

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02816390

Keywords

Navigation